Keyphrases
COVID-19
100%
Biochemical Characterization
50%
Nsp3
50%
Protease Activity
50%
Nanobody
50%
Coronavirus
50%
Plasmid DNA (pDNA)
50%
Reverse Genetics
50%
Papain-like
37%
Protease Domain
37%
Antiviral Activity
10%
MALDI-TOF
6%
IC50
6%
Transmembrane Protein
6%
Cross-reactivity
6%
Deubiquitinase
6%
Clinical Compounds
6%
Multi-domain
6%
Catalytic Domain
6%
SARS-CoV-2 Infection
6%
Protease
6%
Host Cell Proteins
6%
Polypeptide
6%
Infection Cycle
6%
Viral
6%
Ubiquitin-like
6%
Viral Infection
6%
Interferon-stimulated Gene 15 (ISG15)
6%
Infection Assay
6%
Polyubiquitin
6%
Viral Life Cycle
6%
Valuable Insight
6%
Non-structural Protein
6%
Interactome
6%
Substrate Binding Site
6%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Single-Domain Antibody
50%
Plasmid
50%
Coronavirinae
50%
COVID-19
50%
Antiviral Activity
22%
Matrix-Assisted Laser Desorption-Ionization
16%
Cross-Reactivity
16%
Viral Life Cycle
16%
Binding Site
16%
IC50
16%
Viral Disease
16%
Enzyme Active Site
16%
Host Cell
16%
Structural Protein
16%
Ubiquitins
16%
Permissive Cells
5%
Apilimod
5%
Coronavirus
5%
Viral Protein
5%
Transient Transfection
5%
Virus Infectivity
5%
Drug Screening
5%
Cell Line
5%
Biochemistry, Genetics and Molecular Biology
Single-Domain Antibody
50%
SARS Coronavirus
50%
Protease
50%
Papain
37%
Life Cycle
6%
Interactome
6%
Binding Site
6%
Enzyme Active Site
6%
IC50
6%
Matrix-Assisted Laser Desorption-Ionization
6%
Transmembrane Protein
6%
Structural Protein
6%
ISG15
6%
Cross Reaction
6%
Enzyme
6%
Ubiquitin
6%
Membrane Protein
6%
Antiviral Activity
6%